Connection

Paul Gurbel to Proprotein Convertase 9

Back to Details
This is a "connection" page, showing publications Paul Gurbel has written about Proprotein Convertase 9.
Paul Gurbel
Connection Strength
0.362
Proprotein Convertase 9
  1. Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention. Expert Rev Cardiovasc Ther. 2018 Jun; 16(6):419-429.
    View in: PubMed
    Score: 0.164
  2. Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet? J Am Coll Cardiol. 2017 09 19; 70(12):1463-1466.
    View in: PubMed
    Score: 0.156
  3. Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review. Eur Heart J Cardiovasc Pharmacother. 2019 01 01; 5(1):47-54.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.